Aspetuck Financial Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Sell
10,800
-14
-0.1% -$1.62K 0.89% 31
2025
Q4
$1.14M Buy
10,814
+65
+0.6% +$6.1K 0.76% 33
2025
Q3
$902K Buy
10,749
+3,100
+41% +$255K 0.62% 33
2025
Q2
$605K Sell
7,649
-37
-0.5% -$2.94K 0.46% 43
2025
Q1
$690K Sell
7,686
-6,124
-44% -$572K 0.59% 34
2024
Q4
$1.37M Buy
+13,810
New +$1.42M 1.07% 29

Other funds holding MRK

Aspetuck Financial Management's MRK Position: Q1 2026 in Review

Aspetuck Financial Management reduced its Merck (MRK) stake by 0.13% in Q1 2026, selling an estimated $1.62K and leaving 10,800 shares worth $1.3M. The position accounts for 0.89% of the portfolio, ranked #31.

Aspetuck Financial Management first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.37M in Q4 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Aspetuck Financial Management held 10,800 shares of Merck worth $1.3M as of Q1 2026.
  • Aspetuck Financial Management sold 14 Merck shares in Q1 2026, an estimated $1.62K.
  • Merck made up 0.89% of Aspetuck Financial Management's portfolio in Q1 2026, its #31 holding.
  • Aspetuck Financial Management first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Aspetuck Financial Management's Merck position peaked at $1.37M in Q4 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Aspetuck Financial Management's 13F filing for Q1 2026, filed 6 May 2026.